Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $735K | Hold |
1,400
| – | – | 0.38% | 71 |
|
|
2025
Q1 | $888K | Sell |
1,400
-1
| -0.1% | -$634 | 0.56% | 57 |
|
|
2024
Q4 | $998K | Buy |
1,401
+304
| +28% | +$217K | 0.58% | 59 |
|
|
2024
Q3 | $1.15M | Sell |
1,097
-50
| -4% | -$52.6K | 0.73% | 50 |
|
|
2024
Q2 | $1.21M | Sell |
1,147
-50
| -4% | -$52.6K | 0.78% | 43 |
|
|
2024
Q1 | $1.15M | Sell |
1,197
-50
| -4% | -$48.1K | 0.79% | 46 |
|
|
2023
Q4 | $1.1M | Hold |
1,247
| – | – | 0.91% | 36 |
|
|
2023
Q3 | $1.1M | Buy |
1,247
+147
| +13% | +$129K | 0.91% | 36 |
|
|
2023
Q2 | $790K | Buy |
1,100
+150
| +16% | +$108K | 0.69% | 45 |
|
|
2023
Q1 | $781K | Hold |
950
| – | – | 0.8% | 38 |
|
|
2022
Q4 | $685K | Sell |
950
-150
| -14% | -$108K | 0.97% | 34 |
|
|
2022
Q3 | $758K | Buy |
1,100
+200
| +22% | +$138K | 1.28% | 23 |
|
|
2022
Q2 | $532K | Sell |
900
-150
| -14% | -$88.7K | 0.82% | 39 |
|
|
2022
Q1 | $733K | Buy |
+1,050
| New | +$733K | 0.84% | 40 |
|